Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05271669

COVID-19 Immunity and Changes Over Time

Patterns of SARS-CoV-2 Immunity at Household Level and Their Changes Over Time

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,350 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

The risk of household spread of SARS-CoV-2 hinges on both the transmission dynamics of the virus circulating in the community as well as the seroprotection pattern of constituent members, which can be attributed to vaccination and previous infections. This study is conceptualised to assess the dynamicity of SARS-CoV-2 risk at the household level, through monitoring the pattern of seroprotection, in conjunction with the vaccination coverage, history of infection and exposure risk in the setting of Hong Kong.

Detailed description

The aim of this study is to assess the SARS-CoV-2 risk at the household level, with the objectives of (a) determining the coverage of vaccination and its changes over time; (b) monitoring pattern of exposure and history of infection; and (c) evaluating the level of seroprotection and its longitudinal trend. A cohort of households comprising 900 persons would be recruited. Invited participants would be attend the Research Centre for blood sampling and the completion of a simple questionnaire at 3 different timepoints at 12-18 months apart. A questionnaire would be administered to capture the following characteristics: (a) Socio-demographics; (b) History of SARS-CoV-2 infection; (c) adoption of precautionary measures; (d) SARS-CoV-2 testing history and (e) SARS-CoV-2 vaccination uptake. Participants would be tested for SARS-CoV-2 serology. The main markers for measurement are nucleocapsid antibody for inferring past infection, spike antibody for the immunological responses, and seroprotection by SARS-CoV-2 surrogate virus neutralisation test.

Conditions

Timeline

Start date
2022-06-06
Primary completion
2026-07-01
Completion
2027-01-01
First posted
2022-03-09
Last updated
2026-03-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05271669. Inclusion in this directory is not an endorsement.